4//SEC Filing
Kunkel Lori Anne 4
Accession 0001415889-25-003523
CIK 0001672619other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:39 PM ET
Size
5.6 KB
Accession
0001415889-25-003523
Insider Transaction Report
Form 4
Kunkel Lori Anne
Director
Transactions
- Award
Stock Option (right to buy)
2025-02-06+15,368→ 15,368 totalExercise: $22.47Exp: 2035-02-06→ Common Stock (15,368 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2025 annual meeting of the Issuer's stockholders or (ii) the date of the 2026 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001536368
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 5:39 PM ET
- Size
- 5.6 KB